The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III placebo controlled randomized controlled trial using combination therapy for treatment-related fatigue in patients with prostate cancer.
 
Sriram Yennu
No Relationships to Disclose
 
Penny Stanton
No Relationships to Disclose
 
Seungtaek Choi
No Relationships to Disclose
 
Paul Corn
Research Funding - Janssen Oncology (Inst)
 
Lisa Thomas
No Relationships to Disclose
 
Quynh Nguyen
No Relationships to Disclose
 
Minxing Chen
No Relationships to Disclose
 
Chad Tang
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Boston Scientific; Elekta; MOLLI Surgical; Telix Pharmaceuticals
Research Funding - Myriad Genetics (Inst); Noxopharm (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent on the utilization of a monoclonal antibody and we license this for use. We receive royalties <$1000 per year on this license.
Travel, Accommodations, Expenses - Vision RT
Other Relationship - Osler Institute; Wolters Kluwer
 
Sean Mcguire
No Relationships to Disclose
 
Mary Cavanaugh
No Relationships to Disclose
 
Amado Zurita
No Relationships to Disclose
 
Ana Aparicio
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb Pharmaceuticals; Daiichi Sankyo; Genzyme; GlaxoSmithKline; Janssen; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; American Cancer Society; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Daiichi Sankyo Inc.; Genzyme; GlaxoSmithKline; Janssen Research & Development; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Polaris (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; GlaxoSmithKline
 
Sumit Subudhi
Stock and Other Ownership Interests - Apricity Health
Honoraria - Arcus Biosciences; Bristol Myers Squibb; Dendreon; Hervolution; Johnson & Johnson; Merck; Novartis
Consulting or Advisory Role - Pfizer
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Regeneron (Inst); Tarus Therapeutics (Inst)
 
Bilal Siddiqui
Honoraria - Cancer Expert Now; Cardinal Health; Curio Science; DAVA Pharmaceuticals
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Johnson and Johnson; Merck; Pfizer; Survivornet
Research Funding - Amgen (Inst); Cancer Research Institute; Conquer Cancer, the ASCO Foundation; Johnson & Johnson/Janssen (Inst); Prostate Cancer Foundation; Regeneron (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Curio Science; Merck
 
Patrick Pilié
Consulting or Advisory Role - Novartis; Pfizer
Patents, Royalties, Other Intellectual Property - Patent Pending- biomarker
 
Premjit Roy
No Relationships to Disclose
 
Carol Harrison
No Relationships to Disclose
 
Sanjay Shete
Stock and Other Ownership Interests - 23andMe
 
Karen Basen-Engquist
No Relationships to Disclose
 
Eduardo Bruera
Research Funding - PharmaCann (Inst)